The NovoFine needle series ; combines the latest clinical findings with state-of-the-art technology for making needles that cause significantly less pain and require less pressure to perform the injection.
The 6mm short needles contribute to the more predictable insulin absorption, significantly reducing the risk of intramuscular injection.